argenx SE (ARGX)
962.62
+35.41
(+3.82%)
USD |
NASDAQ |
Nov 09, 16:00
959.93
-2.69
(-0.28%)
After-Hours: 18:24
argenx Gross Profit (Annual) : 3.694B for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.694B |
| December 31, 2024 | 1.950B |
| December 31, 2023 | 1.002B |
| December 31, 2022 | 277.12M |
| December 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Autolus Therapeutics Plc | -21.03M |
| Cellectis SA | 53.05M |
| Halozyme Therapeutics, Inc. | 1.091B |
| DBV Technologies SA | -17.67M |
| Akari Therapeutics Plc | 0.00 |